KD6005

· Shanghai Kanda Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KD6005, covering 2026-04-01 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study of KD6005 in Healthy Participants and Participants With Rheumatoid Arthritis (RA) [Phase 1]